Wall Street consensus ratings categorize Houlihan Lokey (HLI) as a solid buy or moderate outperform opportunity, backed by projected revenue expansions in corporate finance and resilient restructuring demand. Institutional analysts point to its strong earnings beats, disciplined capital management, and attractive twelve-month price targets as compelling indicators for investors looking to gain exposure to elite financial advisory equities.